Expanded Indications of Molecular-Targeted Drugs in Perioperative Therapy of Breast Cancer
In recent years, numerous molecular-targeted drugs have become available for the perioperative therapy of breast cancer, bringing about a revolution in breast cancer treatment. Based on comprehensive gene expression analysis, breast cancer is classified into four subtypes, and there are limitations...
Saved in:
| Main Authors: | Eiichiro Noguchi, Sadako Akashi-Tanaka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Tokyo Women's Medical University
2024-06-01
|
| Series: | Tokyo Women's Medical University Journal |
| Subjects: | |
| Online Access: | https://www.jstage.jst.go.jp/article/twmuj/8/0/8_2024003/_pdf/-char/en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted and cytotoxic inhibitors used in the treatment of breast cancer
by: Robert Roskoski Jr.
Published: (2024-12-01) -
Lichenoid dermatitis induced by abemaciclib in a patient with HR+/HER2- breast cancer
by: Edoardo Mortato, et al.
Published: (2024-11-01) -
Systematic Review and Network Meta-Analysis on Treating Hormone Receptor-Positive Metastatic Breast Cancer After CDK4/6 Inhibitors
by: Neha Pathak, et al.
Published: (2025-01-01) -
Clinical Outcomes of Poly(ADP–Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea
by: Hyeong In Ha, et al.
Published: (2024-10-01) -
PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy
by: Mariam Ben Kacem, et al.
Published: (2024-12-01)